From the Guidelines
Antibiotic selection for bacterial infections should be based on the most recent and highest quality evidence, taking into account the type and severity of the infection, as well as the patient's renal function. For pneumonia, the most recent guidelines from 1 recommend the use of amoxicillin 500-875 mg three times daily for 5-7 days for mild community-acquired cases, while more severe cases may require a respiratory fluoroquinolone like levofloxacin 750 mg daily or combination therapy with a beta-lactam plus a macrolide. For skin infections, uncomplicated cellulitis can be treated with cephalexin 500 mg four times daily for 5-10 days, while more severe infections might require intravenous options like vancomycin 15-20 mg/kg every 8-12 hours, as recommended by 1. Urinary tract infections generally respond to nitrofurantoin 100 mg twice daily for 5-7 days (contraindicated in severe renal impairment), trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days, or fosfomycin 3 g single dose, according to 1. In patients with impaired renal function (eGFR <60 ml/min), dosage adjustments are essential, such as reducing levofloxacin to 500 mg every 48 hours with eGFR 20-49 ml/min, and 250 mg every 48 hours with eGFR 10-19 ml/min, as recommended by 1. Vancomycin requires careful monitoring with trough levels and extended dosing intervals, and beta-lactams like ceftriaxone may require dose reduction by 50% in severe renal impairment. Some key points to consider when choosing antibiotics include:
- Assessing renal function before prescribing
- Considering local resistance patterns
- Adjusting therapy based on culture results when available
- Monitoring for adverse effects, particularly in renally impaired patients, as drug accumulation can lead to toxicity
- Using the most recent and highest quality evidence to guide antibiotic selection, such as the guidelines from 1, 1, and 1.
From the FDA Drug Label
2 DOSAGE AND ADMINISTRATION
1 Dosage for Adults The recommended adult dosages and routes of administration are outlined in Table 1 below for patients with creatinine clearance greater than 60 mL/min. ... Table 1: Recommended Dosage Schedule for Cefepime Injection in Adult Patients with Creatinine Clearance (CrCL) Greater Than 60 mL/min ... Adults Moderate to Severe Pneumonia due to S. pneumoniae, P. aeruginosa*, K pneumoniae, or Enterobacter species 1-2 g IV Every 8-12 hours 10 ... Mild to Moderate Uncomplicated or Complicated Urinary Tract Infections, including pyelonephritis, due to E. coli, K. pneumoniae, or P. mirabilis
5-1 g IV Every 12 hours 7-10 ... Moderate to Severe Uncomplicated Skin and Skin Structure Infections due to S. aureus or S. pyogenes 2 g IV Every 12 hours 10
3 Dosage Adjustments in Patients with Renal Impairment Adult Patients Adjust the dose of Cefepime Injection in patients with creatinine clearance less than or equal to 60 mL/min to compensate for the slower rate of renal elimination ... Table 2: Recommended Dosing Schedule for Cefepime Injection in Adult Patients With Creatinine Clearance Less Than or Equal to 60 mL/min
The appropriate antibiotics and dosages for common bacterial infections, such as pneumonia, skin infections, and urinary tract infections, in patients with varying severity of disease and renal function are as follows:
- Pneumonia: 1-2 g IV every 8-12 hours for 10 days in patients with creatinine clearance greater than 60 mL/min.
- Urinary Tract Infections:
- Mild to Moderate: 0.5-1 g IV every 12 hours for 7-10 days.
- Severe: 2 g IV every 12 hours for 10 days.
- Skin and Skin Structure Infections: 2 g IV every 12 hours for 10 days. For patients with impaired renal function, the dosage should be adjusted according to the creatinine clearance, as outlined in Table 2. 2
From the Research
Choosing the Right Antibiotics
When selecting antibiotics for common bacterial infections such as pneumonia, skin infections, and urinary tract infections, several factors must be considered, including the severity of the disease and the patient's renal function 3.
Factors to Consider
- The patient's medical history and current condition
- The likely target organism and its predicted susceptibility profile 3
- The severity of the disease and the patient's renal function
- Local susceptibility patterns and resistance rates 4, 5
- The potential for antibiotic-resistant bacteria 4, 5, 6
Antibiotic Options
- For urinary tract infections, options include nitrofurantoin, fosfomycin, pivmecillinam, fluoroquinolones, and beta-lactams such as amoxicillin-clavulanate 4
- For skin and soft tissue infections, options include ceftriaxone, cephalexin, and cefixime 7
- For pneumonia, options include ceftriaxone, fluoroquinolones, and beta-lactams such as amoxicillin-clavulanate 7
- For Acinetobacter infections, options include carbapenems, polymyxins, sulbactam, piperacillin/tazobactam, tigecycline, and aminoglycosides 6
Dosing Considerations
- The dose and duration of antibiotic therapy should be tailored to the individual patient's needs and the severity of the infection 5
- For patients with impaired renal function, dose adjustments may be necessary to avoid toxicity 7